Get started
Author

S. V. Belenkaya

Observed names: Belenkaya, Svetlana V., S. V Belenkaya, S. V. Belen'kaya, S. V. Belen’kaya, S.V. Belenkaya, Svetlana Belenkaya, Svetlana V. Belenkaya, Svetlana Valer'yevna Belen'kaya, Svetlana Valerievna Belenkaya, С. В. Беленькая, С.В. Беленькая
Observed institutions: Altai State University, Novosibirsk State University, State Research Center of Virology and Biotechnology VECTOR, Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
ORCID: 0000-0002-3883-6335
Observed ORCID: 0000-0002-3883-6335
OpenAlex ID: A5068410324
Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors
2021 · Dmitriy Shcherbakov, Dmitriy Baev, et al. · ACS Medicinal Chemistry Letters · 59
PDF
Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems
2022 · Iuliia A. Merkuleva, Dmitry N. Shcherbakov, et al. · Vaccines · 41
PDF
Biochemical Properties of Recombinant Chymosin in Alpaca (Vicugna pacos L.)
2018 · S. V. Belenkaya, A. P. Rudometov, et al. · Applied Biochemistry and Microbiology · 28
Structure‐ and Interaction‐Based Design of Anti‐SARS‐CoV‐2 Aptamers
2022 · Vladimir Mironov, Irina A. Shchugoreva, et al. · Chemistry - A European Journal · 27
Immunogenic Properties of the DNA Construct Encoding the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
2021 · M. B. Borgoyakova, L. I. Karpenko, et al. · Molecular Biology · 24
PDF
Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
2022 · Iuliia A. Merkuleva, Dmitry N. Shcherbakov, et al. · Viruses · 17
PDF
Basic Biochemical Properties of Recombinant Chymosins (Review)
2020 · S. V. Belenkaya, D. V. Balabova, et al. · Applied Biochemistry and Microbiology · 15
Characterization of the Altai Maral Chymosin Gene, Production of a Chymosin Recombinant Analog in the Prokaryotic Expression System, and Analysis of Its Several Biochemical Properties
2020 · S. V. Belenkaya, A. A. Bondar, et al. · Biochemistry (Moscow) · 15
Biochemical Properties of a Promising Milk-Clotting Enzyme, Moose (Alces alces) Recombinant Chymosin
2023 · Dina V. Balabova, Ekaterina A. Belash, et al. · Foods · 13
PDF
Triterpenic Acid Amides as Potential Inhibitors of the SARS-CoV-2 Main Protease
2022 · Dmitry S. Baev, Mikhail E. Blokhin, et al. · Molecules · 11
PDF
Production of Maral (Cervus elaphus sibiricus Severtzov) Recombinant Chymosin in the Prokaryotic Expression System and the Study of the Aggregate of Its Biochemical Properties Relevant for the Cheese-Making Industry
2020 · S. V. Belenkaya, D. N. Shcherbakov, et al. · Applied Biochemistry and Microbiology · 11
Usnic acid based thiazole-hydrazones as multi-targeting inhibitors of a wide spectrum of SARS-CoV-2 viruses
2023 · Olga I. Yarovaya, Aleksandr S. Filimonov, et al. · New Journal of Chemistry · 10
The Potential of Usnic-Acid-Based Thiazolo-Thiophenes as Inhibitors of the Main Protease of SARS-CoV-2 Viruses
2024 · Olga I. Yarovaya, Aleksandr S. Filimonov, et al. · Viruses · 9
PDF
Synthesis of conjugates of (aR,7S)-colchicine with monoterpenoids and investigation of their biological activity
2023 · E. S. Shchegravina, S. D. Usova, et al. · Russian Chemical Bulletin · 8
PDF
Biochemical and technological properties of moose (Alces alces) recombinant chymosin
2022 · D. V. Balabova, A. P. Rudometov, et al. · Vavilov Journal of Genetics and Breeding · 8
PDF
Synthesis of non-symmetric N-benzylbispidinol amides and study of their inhibitory activity against the main protease of the SARS-CoV-2 virus
2023 · A. I. Dalinger, D. S. Baev, et al. · Russian Chemical Bulletin · 7
PDF
The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper
2023 · Svetlana V. Belenkaya, Iuliia A. Merkuleva, et al. · Frontiers in Bioengineering and Biotechnology · 6
PDF
Can Recombinant Tree Shrew (Tupaia belangeri chinensis) Chymosin Coagulate Cow (Bos taurus) Milk?
2022 · D. V. Balabova, S. V. Belenkaya, et al. · Applied Biochemistry and Microbiology · 5
PDF
Antibodies to the Spike Protein Receptor-Binding Domain of SARS-CoV-2 at 4–13 Months after COVID-19
2022 · Evgeniia A. Kolosova, Olga N. Shaprova, et al. · Journal of Clinical Medicine · 5
PDF
Ursane hybrids with 5-amino-1,2,3,4-thiatriazole, 1-tetrazole-5-thione, and 1-tetrazole-5-amines and study of their inhibition of main SARS-CoV-2 protease
2025 · Sergey A. Popov, Elvira E. Shults, et al. · Steroids · 4
Computer-aided design, synthesis and evaluation of new SARS-CoV-2 Mpro inhibitors based on 1,5,6,7-tetrahydro-4H-indazol-4-one scaffold
2023 · Yuri A. Piven, Veronica G. Zinovich, et al. · Medicinal Chemistry Research · 4
Composition of Lipophilic Components of Rhododendron adamsii Rehd. Ether Extract and Activity against SARS-CoV-2 Main Protease
2023 · T. P. Kukina, I. A. Elshin, et al. · Russian Journal of Bioorganic Chemistry · 4
Development of antiviral drugs based on inhibitors of the SARS-COV-2 main protease
2021 · A.V. Sulimov, Kh.S. Shikhaliev, et al. · Biomeditsinskaya Khimiya · 4
PDF
Analysis of Some Biochemical Properties of Recombinant Siberian Roe Deer (Capreolus pygargus) Chymosin Obtained in the Mammalian Cell Culture (CHO-K1)
2023 · Denis E. Murashkin, Svetlana V. Belenkaya, et al. · Biochemistry (Moscow) · 3
Composition of Lipophilic Components of Rhododendron Adamsay Ether Extract and Ac-tivity Against Sars-cov-2 Main Protease
2022 · Tat'yana Petrovna Kukina, Ivan Aleksandrovich Yelshin, et al. · chemistry of plant raw material · 3
PDF
Works count: 70
Citation count: 370
H-index: 11
I10-index: 12
Year
Topic
Type